Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast for higher-risk adults with community COVID-19 in Dutch primary care
NL-OMON59495Phase 4Completed
- Sponsor
- Maastricht University
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of montelukast in coronavirus disease 2019 (COVID-19), sponsored by Maastricht University. Primary endpoint: Time to recovery within 28 days. Started May 2023; status: completed.
02
Drugs
montelukast
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NL-OMON59495.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON59495.